Volume 5_2 – GREM – Gynecological and Reproductive Endocrinology & Metabolism

Pre-print

Original Article | DOI: 10.53260/grem.245023

Combined oral hormonal contraception – an update

Anna Jelena Britschgi, Gabriele Merki

Pre-print

Original Article | DOI: 10.53260/grem.245022

Impact of low and ultra-low dose estradiol and dydrogesterone on health-related quality of life of postmenopausal women: outcomes from two Phase 3 studies

Tommaso Simoncini, Mulan Ren, Tetiana Tatarchuk, Elke Kahler, Qi Yu, John C. Stevenson, Marcelo Graziano Custodio, Junyi Yang, Rossella E. Nappi

Pre-print

Systematic Review | DOI: 10.53260/grem.245021

A comparison between the anti-Mullerian hormone and ovarian ultrasound for diagnosing polycystic ovary syndrome: A systematic review

Nasreen A. Osman

Pre-print

Short Review | DOI: 10.53260/grem.245024

Menopausal hormone therapy and breast cancer risk: 21 years from the WHI clinical studies

Carlos Rencoret, José L. Neyro, Santiago Palacios

Pre-print

Short Review | DOI: 10.53260/grem.245026

Hormonal contraception and menopausal transition: a short review

Tiziana Fidecicchi, Marisa Ardito, Matilde Giudetti, Stefano Luisi, Tommaso Simoncini

Pre-print

Position Statement | DOI: 10.53260/grem.245025

Position statement of the Latin American Federation of Climacteric and Menopause Societies (FLASCYM) regarding the use of Bioidentical Hormonal Compounds during female mid-life

Cuauhtémoc Celis-Gonzales, María S. Vallejo-Maldonado, Juan E. Blumel, Luis Hernández-Guzmán, Alejandro Paradas-Caba, Nestor Siseles, Zully Benítez-Roa, Hoover Canaval-Erazo, Nilson Roberto De Melo, Peter Chedraui

This site uses cookies to offer you a better browsing experience. Find out more on how we use cookies.